Assenagon Asset Management S.A. Grows Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Assenagon Asset Management S.A. lifted its position in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 171.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 46,931 shares of the company’s stock after acquiring an additional 29,649 shares during the period. Assenagon Asset Management S.A. owned 0.09% of Prestige Consumer Healthcare worth $3,665,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in PBH. Martingale Asset Management L P raised its holdings in Prestige Consumer Healthcare by 0.4% in the 3rd quarter. Martingale Asset Management L P now owns 36,971 shares of the company’s stock valued at $2,666,000 after acquiring an additional 140 shares during the last quarter. Horizon Kinetics Asset Management LLC increased its holdings in shares of Prestige Consumer Healthcare by 4.8% in the third quarter. Horizon Kinetics Asset Management LLC now owns 3,247 shares of the company’s stock valued at $234,000 after purchasing an additional 150 shares during the last quarter. Evergreen Capital Management LLC lifted its position in Prestige Consumer Healthcare by 5.4% during the second quarter. Evergreen Capital Management LLC now owns 3,143 shares of the company’s stock worth $216,000 after buying an additional 160 shares in the last quarter. OLD National Bancorp IN boosted its stake in Prestige Consumer Healthcare by 4.4% during the third quarter. OLD National Bancorp IN now owns 3,974 shares of the company’s stock worth $287,000 after buying an additional 168 shares during the last quarter. Finally, Huntington National Bank grew its holdings in Prestige Consumer Healthcare by 39.9% in the 3rd quarter. Huntington National Bank now owns 635 shares of the company’s stock valued at $46,000 after buying an additional 181 shares in the last quarter. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Price Performance

Prestige Consumer Healthcare stock opened at $79.36 on Wednesday. The company has a debt-to-equity ratio of 0.61, a quick ratio of 2.10 and a current ratio of 3.56. The company has a market capitalization of $3.92 billion, a price-to-earnings ratio of 19.31, a price-to-earnings-growth ratio of 2.20 and a beta of 0.51. The company’s 50 day simple moving average is $80.46 and its 200-day simple moving average is $74.66. Prestige Consumer Healthcare Inc. has a 1 year low of $59.38 and a 1 year high of $86.36.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, November 7th. The company reported $1.09 EPS for the quarter, hitting analysts’ consensus estimates of $1.09. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The company had revenue of $283.79 million for the quarter, compared to analysts’ expectations of $282.09 million. During the same period in the prior year, the firm earned $1.07 earnings per share. The firm’s revenue was down .9% compared to the same quarter last year. As a group, equities research analysts expect that Prestige Consumer Healthcare Inc. will post 4.46 earnings per share for the current year.

Insider Buying and Selling

In other Prestige Consumer Healthcare news, CEO Ronald M. Lombardi sold 10,875 shares of the business’s stock in a transaction on Tuesday, November 19th. The shares were sold at an average price of $82.60, for a total value of $898,275.00. Following the completion of the transaction, the chief executive officer now owns 320,952 shares in the company, valued at $26,510,635.20. The trade was a 3.28 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Adel Mekhail sold 9,063 shares of the company’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $82.00, for a total value of $743,166.00. Following the sale, the executive vice president now directly owns 18,365 shares in the company, valued at $1,505,930. This represents a 33.04 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 38,810 shares of company stock valued at $3,187,300. Corporate insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently commented on PBH shares. Sidoti lowered Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price target on the stock. in a report on Monday, December 9th. Jefferies Financial Group reaffirmed a “hold” rating and set a $76.00 target price (up from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. StockNews.com cut shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a research note on Thursday, January 16th. Raymond James raised shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday, December 19th. Finally, DA Davidson reiterated a “buy” rating and issued a $95.00 price objective on shares of Prestige Consumer Healthcare in a research report on Monday, November 11th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $85.25.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.